Skip to content

An MR imaging study on bioresorbable mm.IF interference screw for graft fixation in ACL repair

An MR imaging study on bioresorbable mm.IF interference screw for graft fixation in ACL repair - mm.IF imaging study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00023966
Enrollment
15
Registered
2022-05-19
Start date
2022-06-06
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

S83.53

Interventions

Group 1: The mm.IF screw is applied in accordance with the manufacturers instructions as part of the routine care for patients undergoing anterior cruciate ligament reconstruction. Surgical interventi

Sponsors

Medical Magnesium GmbH
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Patient is at least 18 years of age at the time of enrollment. (2) Patient requires surgical reconstruction of the anterior cruciate ligament (ACL). (3) Patient must be treated with mm.IF bioresobable interference screw for soft tissue fixation according to the manufacturers instructions for use (4) Ability and willingness to adhere to study follow-up. (5) Patient is able to give informed consent for study participation.

Exclusion criteria

Exclusion criteria: (1) Patient is a minor or incapable of giving informed consent (2) Patient is pregnant or plans to become pregnant during the study (3) Patient of a vulnerable group (Patients with incurable diseases, Patients in nursing homes, Patients in emergency situations, Homeless, nomads or refugees, Patients who are accommodated under deprivation of liberty pursuant to an administrative or court order or permit) (4) Contraindications for the use of mm.IF interference screw according to the manufacturer's instructions (5) History of ligament or meniscal injury or fracture of the affected knee (6) Present tumor or infectious disease or previous local infection or increased risk of infection (7) In the opinion of the investigator, patient has an emotional or neurological condition that would pre-empt the willingness to participate in the study, including mental illness, drug, or alcohol abuse (8) Patient is entered in another investigational drug or device study, or has been treated with an investigational product in the past 30 days (9) Patient is known to be at risk for loss to follow-up or failure to return for scheduled study visits (10) Patient is personally dependent on the investigator or the sponsor of the study Additional MR specific contraindications: (11) Patient carries one of the following implants: Cardiac pacemaker, Defibrillator (ICD), Left Ventricular Assistant Device (LVAD), Cochlea implant, Neurostimulator, Insulin or analgesic pump, Coronary artery implant, Corpus cavernosum implant, Bladder pacemaker, MRI incompatible heart valve replacement (12) Metal shards in close proximity to eyes, brain and/or near vessel (13) Metallic trans- or subdermal jewelry implants (14) Large tattoos made of dyes with metallic contents (15) Magnetically fixed denture (16) Vascular stent implanted less than 72 hours ago (17) Metallic joint prosthesis or other metal implants for bone stabilization implanted less than 6 weeks ago (18) Acute myocardial infarction (19) Claustrophobia (20) MRI examinations are burdensome due to age or individual constitution

Design outcomes

Primary

MeasureTime frame
MR imaging of implanted mm.IF between week 6 and 12 as well as 6, 12, 18 and 24 months after surgery.

Secondary

MeasureTime frame
(1) Clinical success of the graft fixation method up to 6, 12, 18 and 24 months after surgery, defined by the absence of additional unplanned interventions to restore graft fixation on compliant patients. (2) Number of adverse or serious adverse product effects (ADEs/SADEs) up to 24 months after surgery. (3) EQ-5D-5L questionnaire prior to and at 6, 12, 18, and 24 months after primary surgery. (4) PROMs before and 6, 12, 18 and 24 months after surgery: International Knee Documentation Committee Score (IKDC), Knee Injury and Osteoarthritis Outcome Score (KOOS), Tegner Activity Scale, Lysholm Score. (5) Lachman Test to assess knee laxity and graft fixation at 6, 12, 18 and 24 moths after primary surgery using Lachmeter, if available. (6) Knee range of motion prior to and at 6, 12, 18 and 24 months after primary surgery.

Countries

Germany

Contacts

Public ContactChristian;Miguel Weber;Pishnamaz

Uniklinik RWTH Aachen, Klinik Orthopädie, Unfall- und Wiederherstellungschirurgie;Uniklinik RWTH Aachen, Klinik für Orthopädie, Unfall- und Wiederherstellungschirurgie

chrweber@ukaachen.de;mpishnamaz@ukaachen.de02418036161;02418035993

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026